Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
NCT03875716 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111
Last updated 2026-03-13
Summary
This research study is studying lowering the standard dose of radiation and chemotherapy after surgery, to minimize the side effects and improve the quality of life.
Conditions
Interventions
- RADIATION
-
Radiation therapy
Radiation therapy
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Danielle N. Margalit, MD, MPH · Dana-Farber Cancer Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-20
- Primary Completion
- 2027-12-31
- Completion
- 2029-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT01221753 ·Status: TERMINATED ·Phase: PHASE2
-
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
NCT01898494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
NCT01088802 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
NCT04178174 ·Status: RECRUITING ·Phase: PHASE3
-
Surgery and Reducing Ionizing Radiation of the Unknown Primary
NCT06578871 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
NCT03396718 ·Status: RECRUITING ·Phase: NA
-
Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer
NCT01716195 ·Status: COMPLETED ·Phase: PHASE2
-
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
NCT03416153 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
NCT01932697 ·Status: COMPLETED ·Phase: PHASE2
-
Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers
NCT02515877 ·Status: COMPLETED ·Phase: PHASE1
-
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
NCT07044635 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
NCT06563479 ·Status: RECRUITING ·Phase: PHASE3
-
Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer
NCT02703493 ·Status: COMPLETED ·Phase: NA
-
Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
NCT04220749 ·Status: RECRUITING ·Phase: PHASE2
-
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
NCT01530997 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
NCT06902623 ·Status: RECRUITING ·Phase: NA
-
Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma
NCT05119036 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma
NCT03215719 ·Status: RECRUITING ·Phase: PHASE2
-
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
NCT05600842 ·Status: RECRUITING
-
Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer
NCT02908477 ·Status: COMPLETED ·Phase: PHASE3
-
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
NCT02048020 ·Status: COMPLETED ·Phase: PHASE2
-
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
NCT02281955 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
NCT00014118 ·Status: COMPLETED ·Phase: PHASE2
-
HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma
NCT05962242 ·Status: RECRUITING ·Phase: PHASE2
-
Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer
NCT06775756 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3